Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Waste Management, Inc. (WM) Price & Performance

Heron Therapeutics IncTrade
Waste Management, Inc.Trade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Waste Management, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.47 (market cap $91.46M), while Waste Management, Inc. trades at $238.64 (market cap $96.00B). The key difference: Waste Management, Inc. is far larger — about 1049.6× Heron Therapeutics Inc's market cap, and Waste Management, Inc. pays a 1.48% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

HRTXWM
Market Cap
$91.46M$96.00B
Sector
HealthIndustrials
52-Week High
$1.96$246.51
52-Week Low
$0.39$196.77
Enterprise Value
$189.36M$118.73B
Dividend Yield
1.48%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

Waste Management, Inc.

WM trades at $239.26, showing minimal daily movement with a slight 0.02% decline. The stock maintains a bullish technical outlook with strong moving average signals and trades near its pivot point of $241. Fundamentally, the company demonstrates solid revenue growth from $19.7B in 2022 to $25.2B in 2025, though recent quarters show mixed earnings performance with two misses and one beat against expectations.

WM presents a stable investment case with consistent dividend payments and strong analyst support (57% buy ratings), but faces challenges from elevated debt levels and valuation multiples. The consensus price target of $263.57 suggests 10% upside potential, though investors should monitor execution on earnings guidance and debt management in the coming quarters.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About Waste Management, Inc.

Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.

Read more on WM